Evolent Health
EVH
251 hedge funds and large institutions have $3.35B invested in Evolent Health in 2022 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 93 increasing their positions, 74 reducing their positions, and 19 closing their positions.
189% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 19
26% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 74
24% more capital invested
Capital invested by funds: $2.7B → $3.35B (+$650M)
17% more funds holding
Funds holding: 215 → 251 (+36)
5.99% more ownership
Funds ownership: 97.94% → 103.93% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
62% less call options, than puts
Call options by funds: $10.4M | Put options by funds: $27M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$47.6M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$42M |
| 3 |
BlackRock
New York
|
+$39.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$38.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
-$138M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$30.7M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$24.9M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$20.1M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$10.1M |
EVH Hedge Fund Activity: Q3 2022 in Review
251 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2022, worth a combined $3.35B — up 24% from $2.7B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new EVH positions and 19 closed out — a net gain of 36 holders — while 93 added to existing stakes and 74 trimmed.
The largest buyer was Invesco, adding an estimated $47.6M. The largest seller was Engaged Capital, cutting an estimated $138M.
- 251 institutional investors held Evolent Health (EVH) as of Q3 2022, up from 215 in Q2 2022.
- Funds reported $3.35B of Evolent Health stock for Q3 2022, up 24% quarter-over-quarter.
- 55 funds opened new Evolent Health positions in Q3 2022 and 19 closed out, a net change of +36 holders.
- The largest Evolent Health buyer in Q3 2022 was Invesco, an estimated $47.6M added.
- The largest Evolent Health seller in Q3 2022 was Engaged Capital, an estimated $138M sold.
Based on aggregated 13F filings for Q3 2022.